Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Synovis Life Technologies, Inc. (NASDAQ:SYNO.DL)

CAPS Rating: No stars

A diversified medical device company; develops, manufactures and markets products for the surgical and interventional treatment of disease. Business is conducted in two reportable segments, the surgical business and the interventional business.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SYNO.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFPoinkie (98.01)
Submitted September 14, 2009

Speculating on growth from new acquisition.$59M cash - no debt. Cash per share = $5. Renewed focus on direct sales that has proven a past successful growth model. Pegasus acquisition will still hit expenses hard for Q4 09 & Q1 10, but future… More

tenmiles (28.21)
Submitted August 29, 2007

Financial secure company with nearly $4 per share in cash, but technically likely to retrace 8-12% from current $16.30 levels; fudamentally not a "cheap one" even with 39% 3rd quarter revenue growth.

NASDAQ:SYNO.DL VS S&P 500 (SPY)

NASDAQ:SYNO.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about SYNO.DL.

No one has written a Pitch for SYNO.DL stock yet. Tell us why you think SYNO.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in SYNO.DL.

No players have picked SYNO.DL yet. Tell us why you think SYNO.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SYNO.DL.